Financing Update

29 May 2013

Phorm Corporation Limited ("Phorm" or the "Company")

Financing Update

- Convertible Loan Notes of £1.5m repaid -

The Board of Phorm (AIM: PHRM), a leading internet personalisation technology company, is pleased to announce that the convertible loan notes issued to a new investor referred to in the announcement dated 20 March 2013 have been repaid and the related security and all other obligations have been discharged. The Company had previously drawn down the first tranche of the convertible loan notes, being £1.5m. This amount has now been repaid in full along with interest costs of £300,000. These were repaid from the £7.15m placing announced in 23 April 2013.

- ends -

Contact

Phorm Corporation Limited
Andy Croxson (analysts & investors) +44 207 297 2067Lauren Hendry Parsons (media) +44 207 297 2067

Liberum Capital +44 20 3100 2222 (Nominated Advisor and Joint Broker)Chris Bowman
Richard Bootle

Mirabaud Securities LLP +44 20 7321 2508 (Joint Broker)
Jason Woollard
Peter Krens

Hudson Sandler +44 20 7796 4133Charlie Jack
Charlie Barker

About Phorm

Phorm is a global personalization technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

Phorm's industry leading technology enables its ISP partners to offer a new type of online advertising platform and a free consumer internet content feature, ensuring more relevant advertisements and personalized content for opted-in users.

Phorm's advertising platform revolutionizes current standards of online privacy, fully protecting the identity of consumers. Unlike virtually all other targeted advertising propositions, Phorm's solution is completely opt-in. Only those users consenting to the service are profiled and only ever on an anonymous basis.

Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.

Phorm, under a predecessor holding company, was admitted to the AIM market of the London Stock Exchange in 2004.

For more information, please visit: www.phorm.com